<p>(A) FACS analysis of <i>in vivo</i> maturation of spleen CD11c<sup>+</sup> cells 4 h after i.v. injection of 10 µg of imiquimod (left panel) or 1 µg of LPS (right panel) compared to no TLR ligand stimulation equivalent to 1. (B) IL-6 (left panel) and IL-12p40 (right panel) secretion were measured in serum of AEP<sup>+/+</sup> or AEP<sup>−/−</sup> mice 2 h after i.v. injection with imiquimod or PBS. (n = 9 animals for imiquimod; n = 2 animals for PBS; mean ± SEM for A and B, ** p<0.01, *** p<0.001).</p
<p>DCs were generated from (A) C3H/HeN and C3H/HeJ (TLR4 mutant), or (B) C57BL/6 and TLR-2 KO mice, ...
<p>NOD mouse splenocytes were treated with PBS (untreated) or 10 μM chloroquine for 1 h (A, B) or wi...
<p>BMDMs pretreated with PBS or 10 mM EGT for 24 hours were stimulated with 50 nM Pam2CSK4, 100 ng/m...
<p>(A, B) IL-6, KC or IFN-α secretions in supernatants of AEP<sup>+/+</sup> (white bars) or AEP<sup>...
<p>(A) Immunofluorescence microscopy of resting (top) or imiquimod activated (bottom) fibroblast co-...
<p>(A) Human DCs were pre-incubated with 20<i> </i>µg/mL of anti-TLR2, anti-TLR4, or IgG2a (as an is...
<p>(A) Mice were injected i.v. with LPS, and 12 hr later splenocytes stained to identify DC, and exa...
<p>C57BL/6, TLR2<sup>-/-</sup>, TLR4<sup>-/-</sup> or MyD88<sup>-/-</sup> mice were injected <i>i</i...
<p>BMDC from 8-12 week-old mice were expanded with FLT3L and then cultured in the presence or absenc...
<p>DCs from wt, TLR-2<sup>-/-</sup>, or MyD88<sup>-/-</sup> mice were treated with ESAT-6 protein, L...
<p>(A) BMDM (CD11b+ F4/80+ cells) were stained for surface TLR4 expression at the time of harvest, p...
<p><b>A. </b><i>In vitro</i> stimulation of C57BL/6 mouse spleen cells with varying doses of differe...
<p><b>Copyright information:</b></p><p>Taken from "Novel oligodeoxynucleotide agonists of TLR9 conta...
<p>(A) Expression of co-stimulatory molecules on the surface of DCs from WT and TLR2/4<sup>-/-</sup>...
<p>(A) PP cells (5.8×10<sup>5</sup> cells) from WT (white), TLR2<sup>−/−</sup> (black), TLR4<sup>−/−...
<p>DCs were generated from (A) C3H/HeN and C3H/HeJ (TLR4 mutant), or (B) C57BL/6 and TLR-2 KO mice, ...
<p>NOD mouse splenocytes were treated with PBS (untreated) or 10 μM chloroquine for 1 h (A, B) or wi...
<p>BMDMs pretreated with PBS or 10 mM EGT for 24 hours were stimulated with 50 nM Pam2CSK4, 100 ng/m...
<p>(A, B) IL-6, KC or IFN-α secretions in supernatants of AEP<sup>+/+</sup> (white bars) or AEP<sup>...
<p>(A) Immunofluorescence microscopy of resting (top) or imiquimod activated (bottom) fibroblast co-...
<p>(A) Human DCs were pre-incubated with 20<i> </i>µg/mL of anti-TLR2, anti-TLR4, or IgG2a (as an is...
<p>(A) Mice were injected i.v. with LPS, and 12 hr later splenocytes stained to identify DC, and exa...
<p>C57BL/6, TLR2<sup>-/-</sup>, TLR4<sup>-/-</sup> or MyD88<sup>-/-</sup> mice were injected <i>i</i...
<p>BMDC from 8-12 week-old mice were expanded with FLT3L and then cultured in the presence or absenc...
<p>DCs from wt, TLR-2<sup>-/-</sup>, or MyD88<sup>-/-</sup> mice were treated with ESAT-6 protein, L...
<p>(A) BMDM (CD11b+ F4/80+ cells) were stained for surface TLR4 expression at the time of harvest, p...
<p><b>A. </b><i>In vitro</i> stimulation of C57BL/6 mouse spleen cells with varying doses of differe...
<p><b>Copyright information:</b></p><p>Taken from "Novel oligodeoxynucleotide agonists of TLR9 conta...
<p>(A) Expression of co-stimulatory molecules on the surface of DCs from WT and TLR2/4<sup>-/-</sup>...
<p>(A) PP cells (5.8×10<sup>5</sup> cells) from WT (white), TLR2<sup>−/−</sup> (black), TLR4<sup>−/−...
<p>DCs were generated from (A) C3H/HeN and C3H/HeJ (TLR4 mutant), or (B) C57BL/6 and TLR-2 KO mice, ...
<p>NOD mouse splenocytes were treated with PBS (untreated) or 10 μM chloroquine for 1 h (A, B) or wi...
<p>BMDMs pretreated with PBS or 10 mM EGT for 24 hours were stimulated with 50 nM Pam2CSK4, 100 ng/m...